Since 2012 a series of workshops have been held by the Asia Pacific Malaria Elimination Network (APMEN) to discuss G6PD testing in the context of vivax malaria treatment in the Asia Pacific. This evidence concerns the gene G6PD and Plasmodium vivax malaria.